Friday, July 18, 2025
HomeIndustriesBiotechnology

Biotechnology

Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics

Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the...

DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura

IVERIC bio, Inc. and DelSiTech Ltd, announced an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations...

Intravacc and DZNE Awarded EU Funding to Develop Vaccine Against Genetic ALS Variant

Intravacc, a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines and the German Center for Neurogenerative Diseases (DZNE), have...

Inactivation of Suv39h1 Enhances Anti-Tumor Immune Response by Increasing T Cell Activity

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications demonstrating that the histone lysine methyltransferase enzyme Suv39h1 plays...

ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date

ClearMind Biomedical's novel neurosurgical endoscope, the Axonpen System, has completed its First in Man (FIM) clinical trial in Taiwan with outstanding results. The Axonpen System...
0FansLike
0FollowersFollow
spot_img

Hot Topics